Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib may effectively treat folliculitis decalvans.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Alpha-blockers are the most effective and widely used treatment for lower urinary tract symptoms, with minimal side effects.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.